Literature DB >> 10578524

Role of annexin II tetramer in plasminogen activation.

H M Kang1, K S Choi, G Kassam, S L Fitzpatrick, M Kwon, D M Waisman.   

Abstract

The enzymatic cascade triggered by activation of plasminogen has been implicated in a variety of normal and pathologic events, such as fibrinolysis, wound healing, tissue remodeling, embryogenesis, and the invasion and spread of transformed tumor cells. Recent data established that the Ca(2+)- and phospholipid-binding protein, annexin II heterotetramer (AIIt) binds tissue-type plasminogen activator (tPA), plasminogen, and plasmin, and dramatically stimulates the tPA-dependent conversion of plasminogen to plasmin in vitro. Interestingly, the binding of plasmin to AIIt can inhibit the activity of the enzyme, suggesting that plasmin bound to the cell surface is regulated by AIIt. The existing experimental evidence suggests that AIIt is the key physiological receptor for plasminogen on the extracellular surface of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10578524     DOI: 10.1016/s1050-1738(99)00012-2

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  12 in total

Review 1.  Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.

Authors:  Yusuke Shiozawa; Russell S Taichman
Journal:  Exp Hematol       Date:  2012-05-26       Impact factor: 3.084

2.  Crystallographic analysis of calcium-dependent heparin binding to annexin A2.

Authors:  Chenghua Shao; Fuming Zhang; Melissa M Kemp; Robert J Linhardt; David M Waisman; James F Head; Barbara A Seaton
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

3.  Annexin A2 promotes glioma cell invasion and tumor progression.

Authors:  Haiyan Zhai; Suchitra Acharya; Iordanis Gravanis; Saira Mehmood; Roberta J Seidman; Kenneth R Shroyer; Katherine A Hajjar; Stella E Tsirka
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

4.  Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.

Authors:  Taro Sakai; Krishnakumar Balasubramanian; Sourindra Maiti; Jyotsna B Halder; Alan J Schroit
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

5.  Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry.

Authors:  Weiguo Wu; Ximing Tang; Wei Hu; Reuben Lotan; Waun Ki Hong; Li Mao
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 6.  New Insight on the Role of Plasminogen Receptor in Cancer Progression.

Authors:  Seema Kumari; Ramarao Malla
Journal:  Cancer Growth Metastasis       Date:  2015-07-29

Review 7.  Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination.

Authors:  Sarbani Bhattacharya; Victoria A Ploplis; Francis J Castellino
Journal:  J Biomed Biotechnol       Date:  2012-10-14

Review 8.  The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.

Authors:  Patricia A Madureira; Paul A O'Connell; Alexi P Surette; Victoria A Miller; David M Waisman
Journal:  J Biomed Biotechnol       Date:  2012-10-14

9.  Domains I and IV of annexin A2 affect the formation and integrity of in vitro capillary-like networks.

Authors:  Aase M Raddum; Lasse Evensen; Hanne Hollås; Ann Kari Grindheim; James B Lorens; Anni Vedeler
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

10.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.